脊髓空洞至蛛网膜下腔分流术治疗脊髓空洞症
该回顾性系列分析41例脊髓空洞症患者,采用脊髓空洞至蛛网膜下腔分流术治疗,随访3至108个月(平均36个月),37例空洞缩小,除1例外症状改善或稳定,3例术后出现暂时性下肢感觉症状。作者认为该术式对特发性脊髓空洞症及不适合或未响应其他治疗的患者安全有效。
要点
- 41例患者中37例随访时空洞缩小,除1例外症状改善或稳定。
- 术后并发症包括3例暂时性下肢感觉症状、2例暂时性脑脊液漏、1例假性脑膜膨出、1例术后心肌梗死。
- 2例分流管脱位需再手术,另1例因空洞扩大需早期再手术,无分流管阻塞或感染。
核心结论
- 脊髓空洞至蛛网膜下腔分流术对特发性脊髓空洞症及不适合或未响应其他治疗的患者是安全有效的治疗。
研究设计与样本
- 回顾性分析2000年至2016年连续收治的41例脊髓空洞症患者(19例男性,年龄4至79岁),均接受脊髓空洞至蛛网膜下腔分流术,部分患者同时行硬膜扩大成形术。
主要发现
- 41例中特发性脊髓空洞症15例、脊柱创伤13例、Chiari畸形5例、蛛网膜炎4例、脊髓栓系3例、蛛网膜带1例。
- 随访3至108个月(平均36个月),37例空洞缩小,除1例外所有患者症状改善或稳定。
- 术后并发症包括3例暂时性下肢感觉症状、2例暂时性脑脊液漏、1例假性脑膜膨出、1例术后心肌梗死。
- 2例分流管脱位需再手术,另1例因空洞扩大需早期再手术;无分流管阻塞或感染病例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgery for syringomyelia generally aims to treat the underlying cause, if it is known. Optimal management is unclear for idiopathic syringomyelia, or when treatment of the putative cause has failed or is high risk. Syrinx to subarachnoid shunting is an option for these cases; a series is reported to assess the outcomes of this approach. METHODS: We retrospectively analyzed the clinical and radiologic features of a consecutive series of patients with syringomyelia treated with syrinx to subarachnoid shunting. RESULTS: Forty-one patients (19 male, 4-79 years old) were treated from 2000 to 2016, including 15 patients with idiopathic syringomyelia, 13 with spinal trauma, 5 with Chiari malformation, 4 with arachnoiditis, 3 with tethered cord, and 1 with arachnoid bands. The patients were treated with a syrinx to subarachnoid shunt, and a subset also underwent expansile duraplasty. At follow-up (3-108 months, mean 36 months) syrinx size was reduced in 37 patients, and there was improvement or stabilization of symptoms in all but 1 patient. Three patients had temporary lower limb sensory symptoms after surgery. Other complications were 2 transient cerebrospinal fluid leaks, a pseudomeningocoele, and 1 postoperative myocardial infarction. Two cases of shunt dislodgement required reoperation, and a third case required early reoperation for an enlarging syrinx. There were no cases of shunt blockage or infection. CONCLUSIONS: Syrinx to subarachnoid shunting is a safe and effective treatment for idiopathic syringomyelia and for patients who are not suitable for, or have not responded to, other treatment.
引用
- Davidson KA, Rogers JM, Stoodley MA, et al. Syrinx to Subarachnoid Shunting for Syringomyelia. World Neurosurg. 2017. PMID: 29017977. doi:10.1016/j.wneu.2017.09.205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。